57 results
DEFA14A
EVOK
Evoke Pharma Inc
13 May 20
Additional proxy soliciting materials
12:00am
in light of the public health impact of the COVID-19 pandemic.
“We continue to work with the Food and Drug Administration (FDA) during their review … of the Gimoti (metoclopramide) nasal spray New Drug Application (NDA), despite the COVID-19 pandemic,” said David A. Gonyer, R.Ph., President and CEO
8-K
EX-99.1
EVOK
Evoke Pharma Inc
12 May 20
Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its
11:13am
impact of the COVID-19 pandemic.
“We continue to work with the Food and Drug Administration (FDA) during their review of the Gimoti (metoclopramide … ) nasal spray New Drug Application (NDA), despite the COVID-19 pandemic,” said David A. Gonyer, R.Ph., President and CEO of Evoke Pharma. “As the June
8-K
EX-99.1
8cvvctphf45ub
11 Mar 21
Results of Operations and Financial Condition
4:15pm
8-K
wrofu4y
30 Nov 22
Other Events
10:07am
8-K
ld47q
12 May 20
Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its
11:13am
8-K
ikmk6qmjogh0fc0k39
27 Nov 23
Other Events
4:30pm
8-K
ozq3qbz77w4 cddt1
1 May 23
Other Events
4:04pm
8-K
klw ibu1b6u5p
20 Apr 23
Other Events
4:10pm
8-K
3x3ap
17 Feb 22
Other Events
4:10pm